Stratum

Strata Oncology Announces Presentations on Proprietary Multivariate Biomarkers at North America Conference on Lung Cancer and San Antonio Breast Cancer Symposium

Retrieved on: 
Friday, December 1, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, PD-L1, DNA, Stratum, Spacecraft, NACLC, Italy–Latin America Conference, ADC, Algorithm, IRS, Conference, Lung cancer, Biomarker, Immunotherapy, Biology, Medical imaging

The data to be presented includes results for innovative, proprietary predictive biomarkers for response to anti-PD-1/PD-L1 immunotherapy and antibody-drug conjugates (ADCs) -- the Immunotherapy Response Score (IRS) and ADC Treatment Response Score (ADC TRS), respectively. Strata has developed these biomarkers and others using data collected through an observational clinical trial protocol called the Strata Trial® (NCT03061305). All of these biomarkers take advantage of the company’s unique molecular profiling platform that combines DNA and quantitative RNA sequencing on a single small tumor tissue sample.

Key Points: 
  • Strata Oncology, Inc. (“Strata”), a next-generation precision oncology company enabling smarter cancer treatment, today announced that it will present new data in scientific posters at the 2023 North America Conference on Lung Cancer (NACLC) taking place December 1-3, 2023 in Chicago, Illinois and the San Antonio Breast Cancer Symposium (SABCS) taking place December 5-9, 2023 in San Antonio, Texas.
  • Strata has developed these biomarkers and others using data collected through an observational clinical trial protocol called the Strata Trial® (NCT03061305).
  • “Many of the most exciting recent advances in cancer treatment – such as immunotherapy and antibody-drug conjugates – do not currently have biomarkers that can accurately predict response.
  • “We believe that this type of strategy is required to fully realize the potential of precision oncology to improve patient outcomes.

Strata Identity’s Maverics Achieves SOC 2 Type II Certification

Retrieved on: 
Wednesday, November 29, 2023
Data Management, Security, Technology, Software, Networks, Internet, Stratum, Confidentiality, Entrepreneurship, Privacy, Certified Public Accountant, American Institute, System and Organization Controls, AICPA, SOC

Strata Identity , the Identity Orchestration company, today announced that the Maverics Identity Orchestration Platform™ received a System and Organization Controls (SOC) 2 Type II certification which validates that Strata maintains effective system level controls to ensure the highest level of security.

Key Points: 
  • Strata Identity , the Identity Orchestration company, today announced that the Maverics Identity Orchestration Platform™ received a System and Organization Controls (SOC) 2 Type II certification which validates that Strata maintains effective system level controls to ensure the highest level of security.
  • The company received SOC 2 Type I certification last March.
  • Developed by the American Institute of Certified Public Accountants (AICPA), SOC 2 Type II reports on the examination of controls relevant to the trust services criteria categories covering security, availability, processing integrity, confidentiality, and privacy.
  • “The SOC 2 Type II certification provides customers the confidence of knowing that Strata’s Maverics Identity Orchestration Platform meets and exceeds the industry’s strictest standards for security, availability, processing integrity, confidentiality and privacy,” said Topher Marie, Co-Founder and Chief Technology Officer of Strata Identity.

Ekinops Selected by Strata Networks for System-wide Upgrade

Retrieved on: 
Monday, November 13, 2023
Television, Euronext Paris, Wasatch Front, EKI, Carbon footprint, Uinta Basin, Telecommunications, Internet, NMS, Cable television, Online shopping, Stratum

Strata continues to expand and improve its fiber footprint to remain at the forefront of providing best-in-class residential and business services including phone, television, broadband Internet and mobile.

Key Points: 
  • Strata continues to expand and improve its fiber footprint to remain at the forefront of providing best-in-class residential and business services including phone, television, broadband Internet and mobile.
  • Strata's service area is characterized by difficult terrain and includes a diverse demographic including mid-sized urban and remote rural areas.
  • Celestis' easy-to-use interface gives Strata the ability to monitor, troubleshoot and upgrade services at any node from a centralized network operations center, minimizing truck rolls, helping Strata to reduce its carbon footprint.
  • For more information about the Ekinops360 portfolio, please visit https://www.ekinops.com/solutions/optical-transport
    For more information on Ekinops, visit http://www.ekinops.com/
    For more information on Strata, visit https://stratanetworks.com/
    All press releases are published after the close of trading on Euronext Paris.

Strata Clean Energy Announces Power-to-X (P2X) Platform to Turn Clean Energy into Carbon-Free Alternatives for The Net Zero Future

Retrieved on: 
Wednesday, November 1, 2023
Construction & Property, Agriculture, Natural Resources, Environment, Other Manufacturing, Other Transport, Engineering, Urban Planning, Maritime, Air, Logistics, Supply Chain Management, Transport, Manufacturing, Other Energy, Utilities, Oil, Gas, Alternative Energy, Hardware, Energy, Climate Change, Public Transport, Technology, Batteries, Sustainability, Building Systems, Green Technology, Ammonia, EVP, Carbon, Primary energy, P2X, Tier 1, Power, SAF, BESS, Stratum, Renewable energy

Strata Clean Energy, a pioneer in grid-scale renewable energy solutions, is rapidly building a Power-to-X (P2X) development and technology platform to decarbonize segments of the modern economy where direct electrification is not viable.

Key Points: 
  • Strata Clean Energy, a pioneer in grid-scale renewable energy solutions, is rapidly building a Power-to-X (P2X) development and technology platform to decarbonize segments of the modern economy where direct electrification is not viable.
  • “Strata will transform non-dispatchable clean energy into carbon-free alternatives for the modern industrial economy.
  • Our structured power products and merchant BESS development track record underpin our differentiated approach to serving large loads which require hourly matched renewable energy supply,” said Mike Grunow, EVP & General Manager, P2X, Strata Clean Energy.
  • Among the new hires is KJ Plank, Chief Innovation Officer, who is building out the technology, engineering, energy, and procurement teams within P2X at Strata.

Strata’s User Conference Mobilizes Over 2,400 Healthcare Leaders to Address Industry’s Most Pressing Financial Challenges

Retrieved on: 
Wednesday, October 25, 2023
Momentum, Essentia, Essentia Health, Intelligence, Intermountain Health, Microsoft Excel, Progress, Nebraska Medicine, The Power of Habit, Hospital, Lead, Front Lines, Intelligence officer, CPE, University Health Network, LEAP, Risk management, Nursing, Retail, The New York Times, Northwestern Medicine, Stratum

The LIFT23 event highlights use cases and best practices for addressing the challenges facing healthcare provider organizations today, offering leadership panels, product demonstrations and industry thought leadership.

Key Points: 
  • The LIFT23 event highlights use cases and best practices for addressing the challenges facing healthcare provider organizations today, offering leadership panels, product demonstrations and industry thought leadership.
  • This year’s event offered new tools and resources to tackle today’s industry challenges, including new data & intelligence solutions, lessons and insights from LEAP Award winners and peer-led CPE-accredited panels and sessions.
  • "Our healthcare clients are facing a number of challenges, including workforce shortages, new competition, shifts in care settings and other margin pressures,” said John Martino, Strata’s Chief Executive Officer.
  • This extended report combines financial, operational, and claims data from hospitals and physician practices across the country.

TapestryHealth Names Liz Kirk Chief Operating Officer

Retrieved on: 
Tuesday, September 26, 2023
Roper, Long-term care, Office of Strategic Services, Northwestern Medicine, Patient, Health, KLAS, Roper Technologies, Management, Nursing, Stratum

STRATFORD, Conn., Sept. 26, 2023 /PRNewswire/ -- TapestryHealth, a leading health risk management platform that continuously assesses, monitors and accelerates clinical care interventions to chronically ill, medically underserved seniors in long term care settings announced today that Liz Kirk will become Chief Operating Officer. Prior to joining TapestryHealth, Liz was Senior Vice President of Strategic Services at Strata Decision Technology where she led the scaling and expansion of delivery operations as the company grew over twenty-five times during her ten-year tenure.

Key Points: 
  • STRATFORD, Conn., Sept. 26, 2023 /PRNewswire/ -- TapestryHealth, a leading health risk management platform that continuously assesses, monitors and accelerates clinical care interventions to chronically ill, medically underserved seniors in long term care settings announced today that Liz Kirk will become Chief Operating Officer.
  • Prior to joining TapestryHealth, Liz was Senior Vice President of Strategic Services at Strata Decision Technology where she led the scaling and expansion of delivery operations as the company grew over twenty-five times during her ten-year tenure.
  • "Liz is a seasoned leader in health tech and healthcare delivery who consistently delivers financial results by leveraging technology, building high performing teams and streamlining costs," said Mark Hirschhorn, TapestryHealth CEO.
  • "I'm delighted to join TapestryHealth and work towards improving one of the most challenging and under-served elements of the continuum of care," said Ms. Kirk.

Strata Oncology Announces Appointment of Goz Alhir as Senior Vice President of Commercialization

Retrieved on: 
Tuesday, September 26, 2023
Commercialization, Therapy, Senior, Health, ANN, Stratum, Cancer, Lilly, Patient, Medicine, NanoString Technologies, Knowledge, Growth, Science, Nursing

ANN ARBOR, Mich., Sept. 26, 2023 /PRNewswire/ -- Strata Oncology, Inc. ("Strata"), a next-generation precision oncology company enabling smarter cancer treatment, today announced the appointment of Goz Alhir as Senior Vice President, Commercialization. With more than 25 years of healthcare leadership experience, Alhir brings a wealth of knowledge to the role and is eager to join the company in bringing its transformative treatment selection testing to the market.

Key Points: 
  • ANN ARBOR, Mich., Sept. 26, 2023 /PRNewswire/ -- Strata Oncology, Inc. ("Strata"), a next-generation precision oncology company enabling smarter cancer treatment, today announced the appointment of Goz Alhir as Senior Vice President, Commercialization.
  • "It is an honor to join Strata Oncology at such an important time in the company's growth," said Goz Alhir, Senior Vice President, Commercialization, at Strata Oncology.
  • Alhir is a top-performing executive with extensive experience across the oncology healthcare ecosystem, from oncology diagnostics and therapeutics to precision medicine and biopharma.
  • "Strata Oncology is thrilled to welcome Goz to our executive leadership team," said Dan Rhodes, Ph.D., co-founder and CEO of Strata Oncology.

Strata Oncology Announces New Data Supporting Utility of Immunotherapy Response Score to Guide First-Line Treatment Decisions in Non-small Cell Lung Cancer

Retrieved on: 
Thursday, September 7, 2023
IRS, TMB, PD, ANN, Microsatellite instability, Stratum, Drug, Lung cancer, Biomarker, TPS, IHC, Medicare, Patient, Pathology, MSI, Cancer, Chief medical informatics officer, Pembrolizumab, PD-L1, Conference, Medical imaging, Pharmaceutical industry, NSCLC

ANN ARBOR, Mich., Sept. 7, 2023 /PRNewswire/ -- Strata Oncology, Inc. ("Strata"), a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced new data showing its proprietary biomarker algorithm, Immunotherapy Response Score (IRS), supports informed clinical decisions for first-line treatment of patients with non-small cell lung cancer (NSCLC) beyond the standard of care biomarker PD-L1 immunohistochemistry (IHC).

Key Points: 
  • ANN ARBOR, Mich., Sept. 7, 2023 /PRNewswire/ -- Strata Oncology, Inc. ("Strata"), a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced new data showing its proprietary biomarker algorithm, Immunotherapy Response Score (IRS), supports informed clinical decisions for first-line treatment of patients with non-small cell lung cancer (NSCLC) beyond the standard of care biomarker PD-L1 immunohistochemistry (IHC).
  • Strata Oncology announces data supporting utility of IRS score to guide first-line treatment decisions in NSCLC.
  • IRS can potentially guide treatment selection in this important and frequent clinical scenario," said Kat Kwiatkowski, Ph.D., Strata Oncology SVP, Clinical Development.
  • Immunotherapy Response Score is available clinically as part of the Strata SelectTM test, which is covered for Medicare beneficiaries with advanced solid tumors seeking additional treatment.

Strata & Syntellis Coming Together to Accelerate Innovation and Deliver World-Class Service

Retrieved on: 
Tuesday, August 8, 2023
Education, Health, Intelligence, Roper Technologies, Organization, Hospital, Investment, Thoma Bravo, Growth, Madison Dearborn Partners, Flint, Family, Retail, Management, Stratum

Syntellis is a leading provider of enterprise performance management software, data and intelligence solutions for healthcare, higher education and financial institutions.

Key Points: 
  • Syntellis is a leading provider of enterprise performance management software, data and intelligence solutions for healthcare, higher education and financial institutions.
  • Strata and Syntellis will continue to deliver market-leading solutions and world-class service, with an increased focus on accelerating innovation.
  • “Bringing together these talented teams and forward-thinking organizations will allow us to accelerate innovation and continue to build upon our market-leading solutions,” said John Martino, CEO of Strata.
  • Syntellis is now part of the Roper Technologies, Inc. family, and will be integrated with Strata.

Choice Solutions Services, Inc. Announces Recent Assumption of Strata Claims Management, LLC

Retrieved on: 
Friday, July 14, 2023
Insurance, Stratum, Multimedia, MGA, Choice

DALLAS, July 14, 2023 /PRNewswire/ -- Choice Solutions Services, Inc. ("Choice") , a national provider of independent adjusting and third-party claim administration services, is announcing their recent assumption of Strata Claims Management, LLC ("Strata Claims").

Key Points: 
  • DALLAS, July 14, 2023 /PRNewswire/ -- Choice Solutions Services, Inc. ("Choice") , a national provider of independent adjusting and third-party claim administration services, is announcing their recent assumption of Strata Claims Management, LLC ("Strata Claims").
  • With the transaction, Choice adds Strata Claims' extensive experience to its already strong commercial lines division.
  • "We are thrilled to welcome the talented team at Strata Claims to the Choice family," said JT Pouland, CEO of Choice.
  • Mark Burnam, President of Choice, further states "Strata Claims has an excellent reputation and track record of managing commercial habitational claims.